DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,054 | +24.6% | 1,419 | +20.7% | 0.08% | +33.3% |
| Q2 2023 | $282,558 | -4.8% | 1,176 | 0.0% | 0.06% | -4.8% |
| Q1 2023 | $296,717 | -5.7% | 1,176 | -0.8% | 0.06% | -3.1% |
| Q4 2022 | $314,819 | +1.2% | 1,185 | -1.4% | 0.06% | -8.5% |
| Q3 2022 | $311,000 | +3.0% | 1,202 | +0.8% | 0.07% | -5.3% |
| Q2 2022 | $302,000 | -18.4% | 1,192 | -5.5% | 0.08% | -5.1% |
| Q1 2022 | $370,000 | -10.8% | 1,261 | 0.0% | 0.08% | 0.0% |
| Q4 2021 | $415,000 | -12.1% | 1,261 | -18.6% | 0.08% | -30.7% |
| Q3 2021 | $472,000 | +39.2% | 1,550 | +22.9% | 0.11% | +18.8% |
| Q2 2021 | $339,000 | +19.4% | 1,261 | 0.0% | 0.10% | +9.1% |
| Q1 2021 | $284,000 | +1.4% | 1,261 | 0.0% | 0.09% | +4.8% |
| Q4 2020 | $280,000 | +2.9% | 1,261 | 0.0% | 0.08% | -44.7% |
| Q3 2020 | $272,000 | +22.0% | 1,261 | 0.0% | 0.15% | +13.4% |
| Q2 2020 | $223,000 | +4.7% | 1,261 | -14.4% | 0.13% | +45.7% |
| Q3 2019 | $213,000 | -11.2% | 1,473 | -12.1% | 0.09% | -29.2% |
| Q2 2019 | $240,000 | – | 1,676 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
| Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
| Third Point | 2,490,000 | $730,392,000 | 9.51% |
| Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
| 11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
| Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
| Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
| Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
| Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |